| Name | Title | Contact Details |
|---|
JSS Medical Research is a Westmount, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Egg Donation & Gestational Surrogacy services. Since 1996 ConceiveAbilities has professionally partnered with countless physicians and intended parents around the globe to help build families via third party reproduction. More than 20 years navigating the infertility industry has positioned ConceiveAbilities as the best partner to provide an unmatched level of service. Our unique and extensive experience and a reputation built on unparalleled service, knowledge and communication, allows us to cultivate excellent professional relationships with doctors and clinics, in addition to providing our clients, egg donors and surrogates with consistently solid service. Here at ConceiveAbilities, we believe that individuals and couples who have the desire to pursue a family, deserve the best support and resources possible. If you are committed to excellence and would like to join our team of enthusiastic dream-makers, we invite you to browse our webpage highlighting open positions among ConceiveAbilities` multiple locations.
Masimo Corporation is a global medical technology company that develops, manufactures and markets non-invasive patient monitoring products.
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.
SCRI, an industry leader in clinical trials, is dedicated to advancing therapies for patients through clinical research.